Citation Impact
Citing Papers
An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori
2000
Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review
2013 Standout
An evidence-based appraisal of reflux disease management — the Genval Workshop Report
1998
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification
1999 Standout
Classification and Grading of Gastritis
1996 Standout
Functional Gastroduodenal Disorders
2006 Standout
Interpretation of Changes in Health-related Quality of Life
2003 Standout
Kyoto global consensus report onHelicobacter pylorigastritis
2015 Standout
Effect ofMDR1C3435T polymorphism on cure rates ofHelicobacter pyloriinfection by triple therapy with lansoprazole, amoxicillin and clarithromycin in relation toCYP 2C19 genotypes and 23S rRNA genotypes ofH. pylori
2007
Voriconazole serum concentrations in an infant treated for Trichosporon beigelii infection
2003
Proton pump inhibitors, enterochromaffin‐like cell growth and Helicobacter pylori gastritis
1993
Helicobacter pylori Infection and the Development of Gastric Cancer
2001 Standout
Natural history of gastro-oesophageal reflux disease without oesophagitis (NERD) – a reappraisal 10 years on
2003
Changes in gastric mucosa and luminal environment during acid-suppressive therapy: a review in depth
2001
Gastroesophageal Reflux Symptoms and Well-Being in a Random Sample of the General Population of a Swedish Community
2005
Adverse Effects of Long-Term Proton Pump Inhibitor Therapy
2011
Epidemiology of gastro-oesophageal reflux disease: a systematic review
2005 Standout
Changing Patterns of Helicobacter pylori Gastritis in Long‐Standing Acid Suppression
2000
Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN)
2009
Pyroptosis: mechanisms and diseases
2021 Standout
A 5‐decade analysis of 13,715 carcinoid tumors
2003 Standout
Atrophic Gastritis andHelicobacter pyloriInfection in Patients with Reflux Esophagitis Treated with Omeprazole or Fundoplication
1996
The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus
2006 Standout
Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review
2003
Systematic review: proton‐pump inhibitor failure in gastro‐oesophageal reflux disease – where next?
2005
Pyroptosis: A new frontier in cancer
2019 Standout
Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments
2001
Alcohol accumulation promotes esophagitis via pyroptosis activation
2018
Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs
2004
Early events in proton pump inhibitor‐associated exacerbation of corpus gastritis
2003
Potential adverse effects of proton pump inhibitors
2008
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report
2006 Standout
Managing Gastroesophageal Reflux Disease in Primary Care: The Patient Perspective
2005
Interleukin-1 polymorphisms associated with increased risk of gastric cancer
2000 StandoutNature
International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding
2010 Standout
SIDS and Other Sleep-Related Infant Deaths: Expansion of Recommendations for a Safe Infant Sleeping Environment
2011 Standout
Proton Pump Inhibitor Utilization Patterns in Infants
2007
Review article:Helicobacter pyloriand gastro‐oesophageal reflux disease—clinical implications and management
1999
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Efficacy of omeprazole in functional dyspepsia: double‐blind, randomized, placebo‐controlled trials (the Bond and Opera studies)
1998
Pediatric Gastroesophageal Reflux Clinical Practice Guidelines
2018
Paleozoic accretionary and collisional tectonics of the eastern Tianshan (China): Implications for the continental growth of central Asia
2004 Standout
Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease
2004
An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group.
2000
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease
2016 Standout
The Usefulness of a Structured Questionnaire in the Assessment of Symptomatic Gastroesophageal Reflux Disease
1998
Canadian Consensus Conference on the Management of Gastroesophageal Reflux Disease in Adults – Update 2004
2005
Epidemiology of gastric cancer
2006 Standout
Evidence-Based Recommendations for Short- and Long-Term Management of Uninvestigated Dyspepsia in Primary Care: An Update of the Canadian Dyspepsia Working Group (CanDys) Clinical Management Tool
2005
Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease
2013
Mutation of the gastric hydrogen-potassium ATPase alpha subunit causes iron-deficiency anemia in mice
2011 StandoutNobel
Works of A. Dalväg being referenced
Omeprazole for treatment of chronic erosive esophagitis in children: A multicenter study of efficacy, safety, tolerability and dose requirements
2000
Gastric Endocrine Cells and Gastritis in Patients Receiving Long-Term Omeprazole Treatment
1992
Pharmacokinetics of orally administered omeprazole in children
2000
Gastro-oesophageal reflux disease in primary care
1998